A Case of Idiopathic Autoimmune Hemolytic Anemia: Every Anemia – First Type It and Then Treat It
DOI:
https://doi.org/10.59793/ijcp.v34i9.778Keywords:
Autoimmune hemolytic anemia, reticulocyte count, lactate dehydrogenase,, peripheral smearAbstract
Autoimmune hemolytic anemia (AIHA) is a medical disorder where the immune system erroneously targets and destroys
red blood cells (RBCs), causing a reduction in their longevity. This results in an inadequate supply of RBCs to carry oxygen,
leading to symptoms like fatigue, weakness and jaundice. AIHA is categorized into warm and cold types based on the
optimal temperature for antibody activity. A comprehensive grasp of the immunological mechanisms involved is essential
for accurate diagnosis and effective management of this autoimmune condition. AIHA is a frequently missed diagnosis as
patient are not fully investigated, and treated with vitamin B12, folic acid and iron in outpatient department.
Downloads
Published
Issue
Section
License
All open access articles published in IJCP are distributed under the terms of the CC BY-NC 4.0 license (Creative Commons Attribution-Non-Commercial 4.0 International Public License). This license permits unrestricted use, distribution, and reproduction of the articles in any medium for non-commercial purposes, provided that: The original authorship is properly and fully attributed. The IJCP is cited as the original place of publication with correct citation details. If an original work is reproduced or disseminated in part or as a derivative work, this must be clearly indicated. No articles are reproduced for commercial use without prior consent from the IJCP. All licensing requests and permissions for commercial use will be managed by the Publisher.
How to Cite
